BCYC vs ROL · rev $1.5M vs P/E 41, rev $1.99B
Bicycle Therapeutics Ltd (BCYC) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported BCYC revenue for 2026-06-30 was $1.5M. Net income was -$111.2M. Revenue was up 70.9% from 2026-03-31 to 2026-06-30. BCYC currently screens at market cap $554.0M.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
BCYC currently screens at market cap $554.0M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the BCYC and ROL stock pages for the full models.
Not investment advice.